Search for an ETF or holding
Aethlon Medical, Inc. (AEMD) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 3 million USD (micro-cap).
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.